Logo
x

Search

Subscribe Now

patient

Daiichi Sankyo Reports First patient Dosing in P- I/II Trial of DS-1594 to Treat Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Daiichi Sankyo Reports First patient Dosing in P- I/II Trial of DS-1594 to Treat Acute Myeloid Leukemia and Acute Lymphoblastic Le...

  • April 8, 2021
Member of COVID R&D Alliance Report the First Patient Enrollment in COMMUNITY Study

Member of COVID R&D Alliance Report the First Patient Enrollment in COMMUNITY Study

  • December 1, 2020
Xbrane Reports Patient Enrollment Completion in P-lll XPLORE Study of Xlucane (biosimilar- ranibizumab)

Xbrane Reports Patient Enrollment Completion in P-lll XPLORE Study of Xlucane (biosimilar- ranibizumab)

  • November 11, 2020
Thermo Fisher Expands its Direct-to-Patient Service Offerings

Thermo Fisher Expands its Direct-to-Patient Service Offerings

  • October 28, 2020
Eli Lilly Reports Dosing of its First Patient with Tirzepatide in P-III SURPASS-CVOT Study for Cardiovascular Outcomes

Eli Lilly Reports Dosing of its First Patient with Tirzepatide in P-III SURPASS-CVOT Study for Cardiovascular Outcomes

  • June 9, 2020
JHL Biotech Reports Dosing of its First Patient with JHL1266 (biosimilar- denosumab) in P-I Study in Australia

JHL Biotech Reports Dosing of its First Patient with JHL1266 (biosimilar- denosumab) in P-I Study in Australia

  • May 18, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.